AlphaCrest Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,822
| Closed | -$1.26M | – | 900 |
|
|
2022
Q3 | $1.26M | Sell |
1,822
-3,230
| -64% | -$2.22M | 0.08% | 471 |
|
|
2022
Q2 | $2.99M | Buy |
5,052
+1,077
| +27% | +$637K | 0.14% | 167 |
|
|
2022
Q1 | $2.78M | Sell |
3,975
-3,800
| -49% | -$2.65M | 0.16% | 140 |
|
|
2021
Q4 | $4.91M | Buy |
7,775
+105
| +1% | +$66.3K | 0.18% | 98 |
|
|
2021
Q3 | $4.64M | Buy |
7,670
+958
| +14% | +$580K | 0.24% | 69 |
|
|
2021
Q2 | $3.75M | Sell |
6,712
-433
| -6% | -$242K | 0.16% | 173 |
|
|
2021
Q1 | $3.38M | Buy |
7,145
+3,159
| +79% | +$1.49M | 0.19% | 126 |
|
|
2020
Q4 | $1.93M | Buy |
3,986
+2,272
| +133% | +$1.1M | 0.16% | 141 |
|
|
2020
Q3 | $959K | Buy |
1,714
+873
| +104% | +$488K | 0.1% | 271 |
|
|
2020
Q2 | $524K | Sell |
841
-84
| -9% | -$52.3K | 0.09% | 369 |
|
|
2020
Q1 | $452K | Sell |
925
-644
| -41% | -$315K | 0.05% | 616 |
|
|
2019
Q4 | $589K | Sell |
1,569
-12,764
| -89% | -$4.79M | 0.05% | 681 |
|
|
2019
Q3 | $3.98M | Buy |
14,333
+9,163
| +177% | +$2.54M | 0.24% | 59 |
|
|
2019
Q2 | $1.62M | Buy |
+5,170
| New | +$1.62M | 0.14% | 211 |
|